John Sheldon
@jmsheld9
ID: 2847060797
27-10-2014 18:15:24
983 Tweet
946 Takipçi
1,1K Takip Edilen
Great discussion on Type 1 error in #noninferiority trials via Venk Murthy MD PhD Important consideration for #cancer NI trials #radonc #pcsm I’ve heard Howard Sandler mention these issues before Drew Moghanaki Jeff Michalski Daniel E Spratt Dr. Andrew Loblaw Alison Tree 💙 x.com/venkmurthy/sta…
Neil Peart's love of literature and reverence for history deeply informed his songwriting. Read Annie Zaleski's remembrance of the Rush drummer and lyricist: trib.al/vv7iGRv
ORIOLE out in JAMA Oncology: bit.ly/33OAKmR. Metastases directed #SBRT improves PFS over observation. Great work by Phuoc Tran & team. IMHO confirmation needed on larger trial, active comparator (ADT at least) & more robust endpoint. But a great step in right direction.
Bill Gates interviewed for The Economist on covid. Well worth watching. You get a sense of a person who spends his time learning, absorbing tremendous knowledge, seeing the big picture, and trying to do something to make it better. youtube.com/watch?v=m7Stkv…
Payors have embraced the Age of Misdirection—meaning cleverly deflecting the blame for high healthcare costs, while enjoying record profits. Shocking? Not really. Read what health plan executive turned whistleblower, Wendell Potter, has to say about it. bit.ly/2U9P4WL
The overhead view makes Rich Strike's comeback for the upset Kentucky Derby win look even more incredible. 😮 #KyDerby | Churchill Downs
One might think that this is all Congress needs to see to recognize what it needs to do (hint, current senate bill is awfully generous to PBMs and patients still don’t get first dollar coverage… can you fix that?). And yet… No Patient Left Behind
Today is HCC day! - RTOG 1112 - HCC unsuitable for or refractory to local-regional Tx (n=177) - SBRT & Sorafenib vs Sorafenib - After adjustment for stratification factors, improved OS after SBRT (HR 0.72) - Median PFS improved from 5.5 to 9.2 mo (HR 0.55) jamanetwork.com/journals/jamao…